In another study, Wang et al.42 modelled Barth syndrome, a mitochondrial cardiomyopathy disorder caused by mutation of the gene encoding Tafazzin (TAZ), with iPSCs obtained from patients affected by the disease or by Cas9-mediated genome editing to mutate TAZ in a control human line. The gene discussed is TAFAZZIN; the disease is Barth syndrome.